• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.在生理条件下,分泌型 CXCL12(基质细胞衍生因子 1)形成二聚体。
Biochem J. 2012 Mar 1;442(2):433-42. doi: 10.1042/BJ20111341.
2
Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.用于CXCR4和CXCR7细胞研究的生物发光CXCL12融合蛋白。
Biotechniques. 2009 Jul;47(1):625-32. doi: 10.2144/000113126.
3
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.趋化因子 CXCL12 被 CXCR7 清除可促进 CXCR4 阳性乳腺癌细胞的肿瘤生长和转移。
Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.
4
Imaging ligand-dependent activation of CXCR7.成像 CXCR7 配体依赖性激活。
Neoplasia. 2009 Oct;11(10):1022-35. doi: 10.1593/neo.09724.
5
Noninvasive imaging reveals inhibition of ovarian cancer by targeting CXCL12-CXCR4.非侵入性成像显示通过靶向 CXCL12-CXCR4 抑制卵巢癌。
Neoplasia. 2011 Dec;13(12):1152-61. doi: 10.1593/neo.111076.
6
Imaging chemokine receptor dimerization with firefly luciferase complementation.利用萤火虫荧光素酶互补成像趋化因子受体二聚化
FASEB J. 2009 Mar;23(3):823-34. doi: 10.1096/fj.08-116749. Epub 2008 Nov 10.
7
Dual-Color Luciferase Complementation for Chemokine Receptor Signaling.用于趋化因子受体信号传导的双色荧光素酶互补技术
Methods Enzymol. 2016;570:119-29. doi: 10.1016/bs.mie.2015.08.024. Epub 2015 Nov 14.
8
CXCR7 controls competition for recruitment of β-arrestin 2 in cells expressing both CXCR4 and CXCR7.CXCR7在同时表达CXCR4和CXCR7的细胞中控制β-抑制蛋白2募集的竞争。
PLoS One. 2014 Jun 4;9(6):e98328. doi: 10.1371/journal.pone.0098328. eCollection 2014.
9
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.CXCL12-CXCR4/CXCR7 轴在结直肠癌中的作用:临床前和临床研究中的治疗靶点。
Int J Mol Sci. 2021 Jul 9;22(14):7371. doi: 10.3390/ijms22147371.
10
The peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domains.肽拟态趋化因子受体 4 拮抗剂 TC14012 募集β-arrestin 到趋化因子受体 7:受体结构域的作用。
J Biol Chem. 2010 Dec 3;285(49):37939-43. doi: 10.1074/jbc.C110.147470. Epub 2010 Oct 18.

引用本文的文献

1
Biased agonism of G protein-coupled receptors as a novel strategy for osteoarthritis therapy.G蛋白偶联受体的偏向性激动作用作为骨关节炎治疗的新策略。
Bone Res. 2025 May 12;13(1):52. doi: 10.1038/s41413-025-00435-y.
2
Structural insights into CXCR4 modulation and oligomerization.对CXCR4调节和寡聚化的结构见解。
Nat Struct Mol Biol. 2025 Feb;32(2):315-325. doi: 10.1038/s41594-024-01397-1. Epub 2024 Sep 23.
3
Cellular regenerative therapy in stress urinary incontinence: new frontiers?-a narrative review.压力性尿失禁的细胞再生疗法:新前沿?——一项叙述性综述
Transl Androl Urol. 2024 Aug 31;13(8):1709-1716. doi: 10.21037/tau-22-682. Epub 2023 Jul 24.
4
Regulating Chemokine-Receptor Interactions through the Site-Specific Bioorthogonal Conjugation of Photoresponsive DNA Strands.通过光响应 DNA 链的位点特异性生物正交共轭来调节趋化因子-受体相互作用。
Bioconjug Chem. 2023 Nov 15;34(11):2089-2095. doi: 10.1021/acs.bioconjchem.3c00390. Epub 2023 Oct 19.
5
Chemokine Heteromers and Their Impact on Cellular Function-A Conceptual Framework.趋化因子异源二聚体及其对细胞功能的影响——概念框架。
Int J Mol Sci. 2023 Jun 30;24(13):10925. doi: 10.3390/ijms241310925.
6
Associations of Serum CXCL12α and CK Levels with Skeletal Muscle Mass in Older Adults.老年人血清CXCL12α和肌酸激酶水平与骨骼肌质量的相关性
J Clin Med. 2023 May 31;12(11):3800. doi: 10.3390/jcm12113800.
7
CXCR7 as a novel therapeutic target for advanced prostate cancer.CXCR7 作为晚期前列腺癌的新型治疗靶点。
Oncogene. 2023 Mar;42(11):785-792. doi: 10.1038/s41388-023-02597-7. Epub 2023 Feb 9.
8
Bioinformatics Study Identified EGF as a Crucial Gene in Papillary Renal Cell Cancer.生物信息学研究鉴定 EGF 为乳头状肾细胞癌的关键基因。
Dis Markers. 2022 May 24;2022:4761803. doi: 10.1155/2022/4761803. eCollection 2022.
9
Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate.CXCL12/CXCR4/CXCR7 轴在动脉粥样硬化中的作用和意义:仍存在争议。
Ann Med. 2021 Dec;53(1):1598-1612. doi: 10.1080/07853890.2021.1974084.
10
The dimeric form of CXCL12 binds to atypical chemokine receptor 1.CXCL12 的二聚体形式与非典型趋化因子受体 1 结合。
Sci Signal. 2021 Aug 17;14(696):eabc9012. doi: 10.1126/scisignal.abc9012.

本文引用的文献

1
Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.趋化因子 CXCL12 被 CXCR7 清除可促进 CXCR4 阳性乳腺癌细胞的肿瘤生长和转移。
Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.
2
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.利用 Gaussia luciferase 互补作用进行配体-受体结合的体内成像。
Nat Med. 2011 Dec 4;18(1):172-7. doi: 10.1038/nm.2590.
3
Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.单体和二聚体 CXCL12 通过不同的 CXCR4 相互作用和信号通路抑制转移。
Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17655-60. doi: 10.1073/pnas.1101133108. Epub 2011 Oct 11.
4
Video-rate bioluminescence imaging of matrix metalloproteinase-2 secreted from a migrating cell.高速荧光成像术对迁移细胞分泌的基质金属蛋白酶-2 的检测。
PLoS One. 2011;6(9):e25243. doi: 10.1371/journal.pone.0025243. Epub 2011 Sep 28.
5
Combination of drug therapy in acute lymphoblastic leukemia with a CXCR4 antagonist.联合使用 CXCR4 拮抗剂的药物疗法治疗急性淋巴细胞白血病。
Leukemia. 2011 Aug;25(8):1314-23. doi: 10.1038/leu.2011.76. Epub 2011 Apr 12.
6
CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?CXCL12(SDF1alpha)-CXCR4/CXCR7 通路抑制:一种新兴的抗肿瘤治疗增敏剂?
Clin Cancer Res. 2011 Apr 15;17(8):2074-80. doi: 10.1158/1078-0432.CCR-10-2636. Epub 2011 Feb 24.
7
CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity.CXCR7 通过控制自身免疫期间管腔外 CXCL12 的丰度来影响白细胞进入中枢神经系统实质。
J Exp Med. 2011 Feb 14;208(2):327-39. doi: 10.1084/jem.20102010. Epub 2011 Feb 7.
8
Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients.基质衍生因子-1α与脑卒中患者的循环内皮祖细胞及急性病灶体积相关。
Stroke. 2011 Mar;42(3):618-25. doi: 10.1161/STROKEAHA.110.596007. Epub 2011 Jan 21.
9
Cxcr7 controls neuronal migration by regulating chemokine responsiveness.Cxcr7 通过调节趋化因子的反应性来控制神经元迁移。
Neuron. 2011 Jan 13;69(1):77-90. doi: 10.1016/j.neuron.2010.12.006.
10
CXCR4 and CXCR7 have distinct functions in regulating interneuron migration.CXCR4 和 CXCR7 在调节中间神经元迁移方面具有不同的功能。
Neuron. 2011 Jan 13;69(1):61-76. doi: 10.1016/j.neuron.2010.12.005.

在生理条件下,分泌型 CXCL12(基质细胞衍生因子 1)形成二聚体。

Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.

机构信息

Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, MI 48109, U.S.A.

出版信息

Biochem J. 2012 Mar 1;442(2):433-42. doi: 10.1042/BJ20111341.

DOI:10.1042/BJ20111341
PMID:22142194
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4419379/
Abstract

Chemokine CXCL12 (CXC chemokine ligand 12) signalling through CXCR (CXC chemokine receptor) 4 and CXCR7 has essential functions in development and underlies diseases including cancer, atherosclerosis and autoimmunity. Chemokines may form homodimers that regulate receptor binding and signalling, but previous studies with synthetic CXCL12 have produced conflicting evidence for homodimerization. We used bioluminescence imaging with GL (Gaussia luciferase) fusions to investigate dimerization of CXCL12 secreted from mammalian cells. Using column chromatography and GL complementation, we established that CXCL12 was secreted from mammalian cells as both monomers and dimers. Secreted CXCL12 also formed homodimers in the extracellular space. Monomeric CXCL12 preferentially activated CXCR4 signalling through Gαi and Akt, whereas dimeric CXCL12 more effectively promoted recruitment of β-arrestin 2 to CXCR4 and chemotaxis of CXCR4-expressing breast cancer cells. We also showed that CXCR7 preferentially sequestered monomeric CXCL12 from the extracellular space and had minimal effects on dimeric CXCL12 in cell-based assays and an orthotopic tumour xenograft model of human breast cancer. These studies establish that CXCL12 secreted from mammalian cells forms homodimers under physiological conditions. Since monomeric and dimeric CXCL12 have distinct effects on cell signalling and function, our results have important implications for ongoing efforts to target CXCL12 pathways for therapy.

摘要

趋化因子 CXCL12(CXC 趋化因子配体 12)通过 CXCR(CXC 趋化因子受体)4 和 CXCR7 的信号转导在发育过程中具有重要功能,并导致包括癌症、动脉粥样硬化和自身免疫在内的多种疾病。趋化因子可能形成同源二聚体,调节受体结合和信号转导,但以前使用合成 CXCL12 的研究对同源二聚化产生了相互矛盾的证据。我们使用带有 GL(Gaussia 荧光素酶)融合的生物发光成像来研究从哺乳动物细胞分泌的 CXCL12 的二聚化。通过柱层析和 GL 互补,我们确定 CXCL12 从哺乳动物细胞分泌为单体和二聚体。分泌的 CXCL12 也在细胞外空间形成同源二聚体。单体 CXCL12 优先通过 Gαi 和 Akt 激活 CXCR4 信号转导,而二聚体 CXCL12 更有效地促进β-arrestin 2 募集到 CXCR4 并趋化表达 CXCR4 的乳腺癌细胞。我们还表明,CXCR7 优先从细胞外空间隔离单体 CXCL12,并且在细胞测定和人乳腺癌的原位肿瘤异种移植模型中对二聚体 CXCL12 的影响最小。这些研究表明,在生理条件下,从哺乳动物细胞分泌的 CXCL12 形成同源二聚体。由于单体和二聚体 CXCL12 对细胞信号转导和功能有不同的影响,因此我们的研究结果对于为治疗靶向 CXCL12 途径的持续努力具有重要意义。